EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Galectin−1 suppresses FBP1 to activate RAS/ERK signaling and facilitate intrahepatic cholangiocarcinoma progression

Yu Tian, Huiqin Zhou, Junyu Lin, Ke Zhang, Ruiqi He, Huahong Duan, Jiayang Jiang, Yiqun Jiang, Mao Zheng, Mark von Itzstein, Hao Li, Zhenfa Li und 1 weitere

Current Molecular Pharmacology · 2026 · 19 (1) · 181-194

DOI: 10.1016/j.cmp.2026.07.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Molecular Pharmacology, 2026. Verfasst von Yu Tian und 12 weiteren Autor:innen. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Tian, Y., Zhou, H., Lin, J., Zhang, K., He, R., Duan, H., Jiang, J., Jiang, Y., Zheng, M., Itzstein, M. V., Li, H., Li, Z., & Yu, X. (2026). Galectin−1 suppresses FBP1 to activate RAS/ERK signaling and facilitate intrahepatic cholangiocarcinoma progression. Current Molecular Pharmacology, 19(1), 181-194. https://doi.org/10.1016/j.cmp.2026.07.002

Vancouver

Tian Y, Zhou H, Lin J, Zhang K, He R, Duan H, et al. Galectin−1 suppresses FBP1 to activate RAS/ERK signaling and facilitate intrahepatic cholangiocarcinoma progression. Current Molecular Pharmacology. 2026;19(1):181-194. doi:10.1016/j.cmp.2026.07.002

BibTeX
@article{Tian2026,
  author = {Tian, Yu and Zhou, Huiqin and Lin, Junyu and Zhang, Ke and He, Ruiqi and Duan, Huahong and Jiang, Jiayang and Jiang, Yiqun and Zheng, Mao and Itzstein, Mark von and Li, Hao and Li, Zhenfa and Yu, Xing},
  title = {Galectin−1 suppresses FBP1 to activate RAS/ERK signaling and facilitate intrahepatic cholangiocarcinoma progression},
  journal = {Current Molecular Pharmacology},
  year = {2026},
  volume = {19},
  number = {1},
  pages = {181--194},
  doi = {10.1016/j.cmp.2026.07.002}
}
Kostenlos starten →